161 related articles for article (PubMed ID: 29775390)
1. Polarization and Distribution of Tumor-Associated Macrophages and COX-2 Expression in Basal Cell Carcinoma of the Ocular Adnexae.
Kaiser U; Loeffler KU; Nadal J; Holz FG; Herwig-Carl MC
Curr Eye Res; 2018 Sep; 43(9):1126-1135. PubMed ID: 29775390
[TBL] [Abstract][Full Text] [Related]
2. Immunology and growth characteristics of ocular basal cell carcinoma.
Rohrbach JM; Stiemer R; Mayer A; Riedinger C; Duijvestijn A; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2001 Jan; 239(1):35-40. PubMed ID: 11271459
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
5. Distribution and presumed proliferation of macrophages in inflammatory diseases of the ocular adnexae.
Herwig MC; Holz FG; Loeffler KU
Curr Eye Res; 2015 May; 40(6):604-10. PubMed ID: 25111002
[TBL] [Abstract][Full Text] [Related]
6. Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery.
Padoveze EH; Chiacchio ND; Ocampo-Garza J; Cernea SS; Belda W; Sotto MN
Int J Dermatol; 2017 Dec; 56(12):1366-1372. PubMed ID: 28994114
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction.
Tjiu JW; Chen JS; Shun CT; Lin SJ; Liao YH; Chu CY; Tsai TF; Chiu HC; Dai YS; Inoue H; Yang PC; Kuo ML; Jee SH
J Invest Dermatol; 2009 Apr; 129(4):1016-25. PubMed ID: 18843292
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
9. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
[TBL] [Abstract][Full Text] [Related]
11. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
Kaur P; Mulvaney M; Carlson JA
Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
Bartoš V; Kullová M
Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
16. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
17. Histological characteristics of basal cell carcinoma of the eyelid.
Paavilainen V; Aaltonen M; Tuominen J; Saari KM
Ophthalmic Res; 2007; 39(1):45-8. PubMed ID: 17164577
[TBL] [Abstract][Full Text] [Related]
18. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and Factors Related to Eyelid Basal Cell Carcinoma in Saudi Arabia.
Al Wohaib M; Al Ahmadi R; Al Essa D; Maktabbi A; Khandekar R; Al Sharif E; Al Katan H; Schellini SA; Al Shaikh O
Middle East Afr J Ophthalmol; 2018; 25(2):96-102. PubMed ID: 30122855
[TBL] [Abstract][Full Text] [Related]
20. Histological subtypes of periocular basal cell carcinoma.
Wu A; Sun MT; Huilgol SC; Madge S; Selva D
Clin Exp Ophthalmol; 2014; 42(7):603-7. PubMed ID: 24533627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
